Physician
Firer, Leonard
Firer, Leonard was paid $899K by Medicaid between Jan 2018 and Mar 2023, across 39 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoFIRER, LEONARD
REVERE, MA 02151
REVERE, MA 02151
33aNPI1538249263assigned 10/17/2006
33bProvider typePediatrics Physician
28Total paid$899K
24GClaims28,369
24DCodes billed39
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#85 of 1,273
Median peer was paid$24K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,670 | $150K | |
| 2019 | 5,693 | $174K | |
| 2020 | 4,902 | $147K | |
| 2021 | 5,358 | $166K | |
| 2022 | 6,177 | $209K | |
| 2023 | 1,569 | $53K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 4,702 | 4,289 | $273K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 1,340 | 1,256 | $124K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.1% | 2,721 | 2,287 | $82K |
| 92587 | 5.6% | 1,559 | 1,544 | $50K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.2% | 905 | 869 | $46K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.7% | 503 | 503 | $42K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.6% | 352 | 352 | $32K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.7% | 2,713 | 2,707 | $25K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.6% | 950 | 914 | $23K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.4% | 260 | 259 | $22K |
| 99051 | 2.2% | 1,183 | 1,134 | $20K | |
| 90461 | 2.1% | 691 | 688 | $19K |
27 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 2,297 | $17K |
| 99173 | 1.8% | 804 | $16K | |
| 36416 | 1.7% | 1,035 | $16K | |
| 96127 | 1.6% | 1,434 | $15K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 1,162 | $12K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 149 | $12K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 140 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 736 | $9K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 246 | $4K |
| 87081 | <1% | 562 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 26 | $3K |
| 81002 | <1% | 1,026 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 225 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 83 | $3K |
| 87634 | <1% | 37 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 15 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 94 | $2K |
| 83655 | <1% | 134 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 53 | $1K |
| 99384 | <1% | 12 | $1K | |
| 92552 | <1% | 26 | $673.92 | |
| 99177 | <1% | 48 | $569.28 | |
| 80061 | Lipid panel | <1% | 46 | $568.06 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $447.08 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $447.08 |
| 92551 | <1% | 43 | $426.99 | |
| 87070 | <1% | 29 | $387.48 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.